Trademark: 88668612
Status Date
Monday, June 19, 2023
Filing Date
Friday, October 25, 2019
Published for Opposition
Tuesday, March 24, 2020
Abandoned Date
Monday, June 19, 2023
5 Pharmaceuticals for use in the treatment of oncological, autoimmune, infectious, endocrinal, and ocular diseases and disorders; antibodies and protein molecules for use in medical diagnosis and treatment of diseases and disorders
1 Biochemicals, namely, antibodies and protein molecules for use in in vitro scientific or research use
Jun 20, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 19, 2023
Abandonment - No Use Statement Filed
Nov 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2022
Sou Extension 5 Granted
Nov 4, 2022
Sou Extension 5 Filed
Nov 4, 2022
Sou Teas Extension Received
May 5, 2022
Notice Of Approval Of Extension Request E-Mailed
May 3, 2022
Sou Extension 4 Granted
May 3, 2022
Sou Extension 4 Filed
May 3, 2022
Sou Teas Extension Received
Nov 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2021
Sou Extension 3 Granted
Nov 16, 2021
Sou Extension 3 Filed
Nov 16, 2021
Sou Teas Extension Received
May 15, 2021
Notice Of Approval Of Extension Request E-Mailed
May 13, 2021
Sou Extension 2 Granted
May 13, 2021
Sou Extension 2 Filed
May 13, 2021
Sou Teas Extension Received
Jan 26, 2021
Corrected Noa E-Mailed
Jan 26, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 25, 2021
Sou Extension 1 Granted
Nov 13, 2020
Sou Extension 1 Filed
Jan 25, 2021
Divisional Processing Complete
Jan 21, 2021
Divisional Request Received
Dec 7, 2020
Case Assigned To Intent To Use Paralegal
Nov 13, 2020
Teas Request To Divide Received
Nov 13, 2020
Sou Teas Extension Received
May 19, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 24, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 24, 2020
Published For Opposition
Mar 4, 2020
Notification Of Notice Of Publication E-Mailed
Feb 14, 2020
Approved For Pub - Principal Register
Feb 13, 2020
Teas/Email Correspondence Entered
Feb 12, 2020
Correspondence Received In Law Office
Feb 12, 2020
Teas Response To Office Action Received
Feb 8, 2020
Notification Of Priority Action E-Mailed
Feb 8, 2020
Priority Action E-Mailed
Feb 8, 2020
Priority Action Written
Jan 31, 2020
Assigned To Examiner
Oct 30, 2019
New Application Office Supplied Data Entered
Oct 29, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
